<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Open Congress : Blog Articles for H.R.1432 Preserve Access to Affordable Generics Act</title>
  <link href="http://www.opencongress.org/bill/110-h1432/atom_blogs" rel="self"/>
  <link href="http://www.opencongress.org/bill/110-h1432/blogs" rel="alternate"/>
  <updated>2008-08-27T00:00:00Z</updated>
  <author>
    <name>opencongress.org</name>
  </author>
  <id>tag:opencongress.org,2007:/bill/blog/41861</id>
  <entry>
    <title>mlb hall of fame indicators: hitters</title>
    <link href="http://nosebleedseatsblog.blogspot.com/2008/08/mlb-hall-of-fame-indicators-hitters.html" rel="alternate"/>
    <id>tag:opencongress.org,2008-08-27:/commentary/3161925</id>
    <updated>2008-08-27T00:00:00Z</updated>
    <author>
      <name>Nosebleed Seats (and other misfortunes... </name>
    </author>
    <content type="html">
6) luis gonzalez: 353 hr/1432 rbi/2579 h/.283 ba there's no doubt that bonds, griffey and sheffield will eventually make it to cooperstown. they will be first-ballot hofers. the other three are more interesting cases. ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://nosebleedseatsblog.blogspot.com/2008/08/mlb-hall-of-fame-indicators-hitters.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Congress Says Squeeze and Swallow</title>
    <link href="http://blip.tv/file/516888" rel="alternate"/>
    <id>tag:opencongress.org,2007-12-02:/commentary/1480360</id>
    <updated>2007-12-02T00:00:00Z</updated>
    <author>
      <name>- blip.tv (beta) </name>
    </author>
    <content type="html">
Appearing In This Episode: The Issue: Preserve Access to Affordable Generics Act (S.316, HR.1432) The Villains: Congress and the pharmaceutical industry The Victims: The American People Metaphors: Sliced, Squeezed, Vitamin C, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://blip.tv/file/516888&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>congress says squeeze and swallow</title>
    <link href="http://politicalkitchen.com/?p=95" rel="alternate"/>
    <id>tag:opencongress.org,2007-12-02:/commentary/3161928</id>
    <updated>2007-12-02T00:00:00Z</updated>
    <author>
      <name>politicalkitchen.com </name>
    </author>
    <content type="html">
appearing in this episode:the issue: preserve access to affordable generics act (s.316, hr.1432)the villains: congress and the pharmaceutical industrythe victims: the american people metaphors: sliced, squeezed, vitamin c, sucked dry, ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://politicalkitchen.com/?p=95&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Reverse Payments Delay Introduction of Generic Drugs</title>
    <link href="http://pudsandlosers.blogspot.com/2007/11/reverse-payments-delay-introduction-of.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-11-13:/commentary/1480359</id>
    <updated>2007-11-13T00:00:00Z</updated>
    <author>
      <name>Adirondack Musing </name>
    </author>
    <content type="html">
HR 1432 and S. 316, the preserve access to generics acts, propose to make reverse payments illegal. Reverse payments are kind of like the Farm Bill. You get paid for doing nothing. This benefits both the brand name and generic drug ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://pudsandlosers.blogspot.com/2007/11/reverse-payments-delay-introduction-of.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>former ftc staffer recommends a &#226;&#8364;&#339;moderate approach&#226;&#8364;* to &#226;&#8364;&#339;reverse ...</title>
    <link href="http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2007/05/waxman_introduc.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-05-09:/commentary/3161926</id>
    <updated>2007-05-09T00:00:00Z</updated>
    <author>
      <name>FDA Law Blog </name>
    </author>
    <content type="html">
hr 1432 would add a second report requiring parties to file with the assistant attorney general and the ftc &#226;&#8364;&#339;a description of the subject matter of any other agreement the parties enter into within 30 days of an entering into an ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2007/05/waxman_introduc.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>HR 1432 Introduced</title>
    <link href="http://www.legis.state.tx.us/tlodocs/80R/billtext/html/HR01432I.htm" rel="alternate"/>
    <id>tag:opencongress.org,2007-04-05:/commentary/2988689</id>
    <updated>2007-04-05T00:00:00Z</updated>
    <author>
      <name>Texas Legislature - Today&amp;#39;s Bill Text </name>
    </author>
    <content type="html">
In memory of Stephen Daniel Lindsey.&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.legis.state.tx.us/tlodocs/80R/billtext/html/HR01432I.htm&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Intellectual Property Law Blog: Supreme Court Invites Guidance ...</title>
    <link href="http://www.intellectualpropertylawblog.com/archives/patents-supreme-court-invites-guidance-from-solicitor-general-regarding-whether-to-review-reverse-payments-for-settling-of-patent-litigation.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-23:/commentary/3577640</id>
    <updated>2007-03-23T00:00:00Z</updated>
    <author>
      <name>Intellectual Property Law Blog </name>
    </author>
    <content type="html">
See Preserve Access to Affordable Generics Act, H.R. 1432, 73 PTCJ 461, 2/23/07; see also 73 PTCJ 461, 2/23/07. While legislative bills are likely to be tailored to the pharmaceutical industry, judicial decisions will likely cover all ...&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.intellectualpropertylawblog.com/archives/patents-supreme-court-invites-guidance-from-solicitor-general-regarding-whether-to-review-reverse-payments-for-settling-of-patent-litigation.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>HR 1432, To prohibit brand name drug companies from compensating ...</title>
    <link href="http://www.washingtonwatch.com/bills/show/110_HR_1432.html" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-08:/commentary/473022</id>
    <updated>2007-03-08T00:00:00Z</updated>
    <author>
      <name>washingtonwatch.com - Welcome to washingtonwatc... </name>
    </author>
    <content type="html">
HR 1432 would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market....&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.washingtonwatch.com/bills/show/110_HR_1432.html&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
  <entry>
    <title>Bill Action: Introduced: HR 1432: To prohibit brand name drug ...</title>
    <link href="http://www.govtrack.us/congress/bill.xpd?bill=h110-1432" rel="alternate"/>
    <id>tag:opencongress.org,2007-03-08:/commentary/444327</id>
    <updated>2007-03-08T00:00:00Z</updated>
    <author>
      <name>GovTrack.us Monitored Events </name>
    </author>
    <content type="html">
Henry Waxman [D-CA] introduced HR 1432: To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.. [This event matched these monitors: Introduced Legislation ]&lt;br /&gt;&lt;br /&gt;&lt;a href=&quot;http://www.govtrack.us/congress/bill.xpd?bill=h110-1432&quot;&gt;Go to article&lt;/a&gt;    </content>
  </entry>
</feed>
